Mass Treatment to Eliminate Filariasis in Papua New Guinea | Zendy

Moses J. Bockarie | Zendy; Daniel J. Tisch | Zendy; Will Kastens | Zendy; Neâl Alexander | Zendy; Zachary Dimber | Zendy; Florence Bockarie | Zendy; Ervin Ibam | Zendy; Michael P. Alpers | Zendy; James W. Kazura | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Mass Treatment to Eliminate Filariasis in Papua New Guinea

Author(s) -

Moses J. Bockarie,

Daniel J. Tisch,

Will Kastens,

Neâl Alexander,

Zachary Dimber,

Florence Bockarie,

Ervin Ibam,

Michael P. Alpers,

James W. Kazura

Publication year - 2002

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa021309

Subject(s) - diethylcarbamazine , lymphatic filariasis , wuchereria bancrofti , microfilaria , medicine , filariasis , ivermectin , hydrocele , mass drug administration , population , regimen , transmission (telecommunications) , incidence (geometry) , chyluria , surgery , veterinary medicine , immunology , helminths , environmental health , lymphatic system , physics , optics , electrical engineering , engineering

The global initiative to eradicate bancroftian filariasis currently relies on mass treatment with four to six annual doses of antifilarial drugs. The goal is to reduce the reservoir of microfilariae in the blood to a level that is insufficient to maintain transmission by the mosquito vector.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research